Keyword: Gilead Sciences


Gilead Buys Oxford Spin-out MiroBio

10.08.2022 -

Gilead Sciences has agreed to acquire MiroBio, a privately held UK biotech focused on treating inflammatory diseases, for about $405 million in cash.


BioNTech Buying Cell Therapy Plant from Kite

21.07.2021 -

Germany’s BioNTech, best known publicly for the Covid-19 vaccine Comirnaty it developed in partnership with US drugs giant Pfizer, has announced plans to buy a cell...

Chemistry & Life Sciences

Innovation and Creativity in the Pharmaceutical Industry

30.04.2021 -

The International Society for Pharmaceutical Engineering (ISPE) announced the 2021 Facility of the Year Awards (FOYA) Category Winners—including two winners of Special...


Drugs and Maybe Covid Vaccines Headed to India

28.04.2021 -

As India’s Covid-19 infections soar and the death toll nears 200,000, wealthier countries – including the US, UK, Germany, France and Australia – are rushing supplies of...


Gilead Takes Immunomedics for $21 Billion

16.09.2020 -

Gilead Sciences is to acquire Immunomedics for approximately $21 billion. The deal, unanimously approved by both companies' boards of directors, will be funded by $15...


FDA Extends EUA for Remdesivir in Covid Patients

02.09.2020 -

The US Food and Drug Administration (FDA) has come under fire again as the federal health agency issued its third Emergency Use Authorization (EUA) for a Covid-19...


Pfizer Teams up with Gilead to Make Remdesivir

11.08.2020 -

After teaming up with Germany’s BioNTech to develop a vaccine for Covid-19, US drugs giant Pfizer is joining US Gilead Sciences on the therapeutic side. The biopharma...


EU Inks Remdesivir Supply Deal with Gilead

30.07.2020 -

The European Commission has signed a €63 million contract with Gilead Sciences to deliver batches of Veklury, Gilead’s name for the antiviral remdesivir, to the EU’s 27...